Skip to main content

Year: 2021

Vera Bradley and Warner Bros. Consumer Products Debut New Harry Potter™ + Vera Bradley Collection

Wizarding World™-inspired, limited-edition “Luna’s Medallion” Collection Now AvailableHarry Potter™ + Vera Bradley Luna’s Medallion CollectionThe Harry Potter™ + Vera Bradley Luna’s Medallion collection is available exclusively on www.verabradley.com and at Harry Potter New York, the official Harry Potter™ flagship store in New York City.FORT WAYNE, Ind., Dec. 06, 2021 (GLOBE NEWSWIRE) — Vera Bradley, Inc. (Nasdaq: VRA; “Vera Bradley” or the “Company”), a leading American bag and luggage company and iconic lifestyle brand, today debuted the Harry Potter™ + Vera Bradley Luna’s Medallion collection, a new limited-edition capsule collection in collaboration with Warner Bros. Consumer Products. Fan favorite Luna Lovegood™, her distinct flair for fashion, and the dreamy, kaleidoscopic view seen through her signature...

Continue reading

Adverum Biotechnologies Appoints Rupert D’Souza, Ph.D., M.B.A. as Chief Financial Officer

REDWOOD CITY, Calif., Dec. 06, 2021 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced that Rupert D’Souza, Ph.D., M.B.A., has joined Adverum as the company’s chief financial officer (CFO). Dr. D’Souza will serve as a member of Adverum’s executive committee and will report to Laurent Fischer M.D., president and chief executive officer at Adverum Biotechnologies. Dr. D’Souza will provide leadership for the company’s financial operations and planning, accounting, procurement, and select other functions. “On behalf of the entire company, I am delighted to welcome Rupert to Adverum and look forward to partnering with him as we advance the company’s strategy together,” said Dr. Laurent Fischer, president and...

Continue reading

Kandi Technologies Announces Share Buy Back of Up to $20 Million

Jinhua, China, Dec. 06, 2021 (GLOBE NEWSWIRE) — Kandi Technologies Group, Inc. (NASDAQ GS: KNDI) (the “Company” or “Kandi”) today announced that its Board of Directors has authorized the Company to repurchase up to $20 million of the Company’s common stock.  The plan authorizes purchases at management’s discretion when the stock trades in a price range that the board believes represents a compelling use of cash.  Kandi expects to commence the repurchase plan on December 10, 2021 and to conclude the plan by the end of 2022.  Progress on the program will be disclosed each report on Form 10-K or Form 10-Q, as the case may be.Mr. Hu Xiaoming, Chairman and Chief Executive Officer of Kandi commented, “We believe that the market is not valuing Kandi appropriately, and that we are significantly undervalued at...

Continue reading

RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81

Glen Rock, N.J., Dec. 06, 2021 (GLOBE NEWSWIRE) — RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of neuronal signaling, is pleased to announce that scientists associated with the Company have published a review article entitled “GABAkines – Advances in the discovery, development, and commercialization of positive allosteric modulators of GABAA receptors” in the peer reviewed journal Pharmacology and Therapeutics (Elsevier, https://doi.org/10.1016/j.pharmthera.2021.108035). The multidisciplinary team of authors was led by Drs. James M. Cook and Jeffrey M. Witkin, both of whom are RespireRx Research Fellows and Dr. Rok Cerne, RespireRx Senior Research Scientist, in addition to...

Continue reading

Invesco Ltd. Form 8.3 Clinigen Group Plc

FORM 8.3 PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION     (a) Full name of discloser: Invesco Ltd.  (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree Clinigen Group Plc  (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:    (e) Date position held/dealing undertaken:For an opening position disclosure, state the latest practicable date prior...

Continue reading

TOMI launches SteraMist Amazon Store featuring the SteraPak SteraPak Leading Disinfection System for All Industries

FREDERICK, Md., Dec. 06, 2021 (GLOBE NEWSWIRE) — TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), is a global company specializing in disinfection and decontamination, utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist products – a hydrogen peroxide-based mist and fog composed of ionized Hydrogen Peroxide (iHP). TOMI has launched the SteraMist Amazon Store which includes the SteraPak and our BIT solution. The Amazon digital storefront expands our sales channels which allows TOMI to optimize and streamline the buying process for our customers. The launching of the SteraMist Amazon Store with the recent launch of our SteraPak has generated significant interest in the commercial space. Ease-of-purchase remains a critical aspect of our target market and listing on Amazon will allow...

Continue reading

ElectraMeccanica SOLO EV Sales Update

Announces Total of 42 SOLO EVs Delivered to Consumers & FleetsConsumers and industry participants evaluate the SOLO EV at the Los Angeles Auto ShowConsumers and industry participants evaluate the SOLO EV at the Los Angeles Auto ShowConsumers and industry participants test drive the SOLO EV at the Los Angeles Auto ShowConsumers and industry participants test drive the SOLO EV at the Los Angeles Auto ShowVANCOUVER, British Columbia, Dec. 06, 2021 (GLOBE NEWSWIRE) — ElectraMeccanica Vehicles Corp. (NASDAQ: SOLO) (“ElectraMeccanica” or the “Company”), a designer and manufacturer of electric vehicles revolutionizing the urban driving experience, today announced as of November 30, 2021 the Company has delivered a total of 42 SOLO EVs to reservation and fleet holders. Delivery of SOLO’s...

Continue reading

Ev Dynamics to Present at Sequire Clean Tech & EV Conference, December 6, 2021

HONG KONG, Dec. 06, 2021 (GLOBE NEWSWIRE) — Ev Dynamics (Holdings) Limited (HK: 0476) (OTC: CHDHF), a leading developer and manufacturer of new energy vehicles (NEVs), has been invited to present at the Sequire Clean Tech & EV Conference being held virtually December 6, 2021. The event will feature presentations from premier innovators in the clean tech space, one-on-one meetings, and keynotes from industry experts. Ev Dynamics CEO, Miguel Valldecabres, is scheduled to present on Monday, December 6, at 2:30 p.m. Eastern time (11:30 a.m. Pacific time), and will hold one-on-one meetings with institutional analysts and investors. Register to watch the presentation here. Management will discuss the company’s expanding global reach into Europe, Southeast Asia and South America through strategic investments and key partnerships,...

Continue reading

GreenBox POS Management to Host Corporate Update Call on Thursday, December 9th at 4:30pm ET

Management to Discuss Recent Progress on Key Acquisitions and Partnerships as well as the Upcoming Spinoff of Coyni SAN DIEGO, CA, Dec. 06, 2021 (GLOBE NEWSWIRE) — GreenBox POS (NASDAQ: GBOX) (“GreenBox” or the “Company”), an emerging financial technology company leveraging proprietary blockchain security and token technology to build customized payment solutions today announced it will host a corporate update call on Thursday, December 9, 2021 at 4:30 p.m. EST. GreenBox Chairman, Ben Errez, will be joined by several key members of management to provide an operational update on the Company’s strategic growth initiatives and technology development before concluding with a question-and-answer session. To participate, please use the following information: Date: Thursday, December 9, 2021Time: 4:30 p.m. EST...

Continue reading

Neuronetics Announces Key Role for NeuroStar Advanced Therapy at 4th International Brain Stimulation Conference

Symposium to Highlight World’s Largest Depression Outcomes Registry MALVERN, Pa., Dec. 06, 2021 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced today their leadership role at the 4th International Brain Stimulation Conference December 6-9 in Charleston, South Carolina as the Platinum Sponsor of the conference. “We are honored to attend and participate in the 4th International Brain Stimulation Conference, an important meeting that takes a multidisciplinary approach to the science that is driving advances in this field,” said Keith J. Sullivan, President and CEO of Neuronetics. “NeuroStar® Advanced Therapy has pioneered the industry...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.